CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
therapy per local standard of care (SoC), best supportive care (BSC)) on protocol survivor follow up) in patients with advanced non-ocular melanoma...
Phase 2, Phase 3
Salt Lake City, Utah, United States and 70 other locations
binimetinib, and pembrolizumab) given together for the treatment of melanoma that:is advanced or metastatic (spread to other parts of the bo...
Phase 3
Salt Lake City, Utah, United States and 227 other locations
efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate lesions (IL) or small choroidal melanoma...
Phase 3
Salt Lake City, Utah, United States of America and 37 other locations
(Spartalizumab (PDR001)), a BRAF inhibitor (dabrafenib) and a MEK inhibitor (trametinib) in unresectable or metastatic BRAF V600 mutant melanoma...
Phase 3
Salt Lake City, Utah, United States and 178 other locations
This is an open-label, 3-arm, fixed-sequence study to evaluate the effect of single and multiple oral doses of encorafenib in combination with binime...
Phase 1
West Valley City, Utah, United States and 27 other locations
not worse than nivolumab + relatlimab FDC intravenous (IV) administration in participants with previously untreated metastatic or unresectable melanoma...
Phase 3
Murray, Utah, United States and 189 other locations
be those with pathological diagnosis of unresectable or metastatic melanoma who are progressing or have progressed on either pembrolizumab o...
Phase 2
Salt Lake City, Utah, United States and 32 other locations
defactinib in combination with avutometinib in brain metastases from melanoma, and to define the potential role of the combination with muta...
Phase 1, Phase 2
Salt Lake City, Utah, United States
trial, 20 adult subjects (≥ 18 years of age) with advanced non-melanoma skin cancers will receive a fixed dose of 0.1 mg of IFx-Hu2.0 intral...
Phase 1
Salt Lake City, Utah, United States and 3 other locations
UV1 is a therapeutic cancer vaccine that has been explored in prostate and lung cancers, and in combination with ipilimumab in malignant melanoma...
Phase 1
Salt Lake City, Utah, United States and 3 other locations
Clinical trials
Research sites
Resources
Legal